T
Tiffany Shih
Researcher at Precision Health Economics
Publications - 12
Citations - 349
Tiffany Shih is an academic researcher from Precision Health Economics. The author has contributed to research in topics: Population & Health care. The author has an hindex of 4, co-authored 11 publications receiving 209 citations.
Papers
More filters
Journal ArticleDOI
Short-term costs of preeclampsia to the United States health care system.
Warren Stevens,Tiffany Shih,Devin Incerti,Thanh G.N. Ton,Henry C. Lee,Desi Peneva,George A. Macones,Bahaeddine M Sibai,Anupam B. Jena +8 more
TL;DR: In 2012, the cost of preeclampsia within the first 12 months of delivery was $2.18 billion in the United States ($1.03 billion for mothers and $1.15 billion for infants), and was disproportionately borne by births of low gestational age.
Journal ArticleDOI
The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health.
Tiffany Shih,Desi Peneva,Xiao Xu,Amelia Sutton,Elizabeth W. Triche,Richard A. Ehrenkranz,Michael J. Paidas,Warren Stevens +7 more
TL;DR: Preeclampsia is one of the top six causes of maternal mortality in the United States and is associated with considerable perinatal morbidity and mortality, but these conditions currently lack effective treatment.
Journal ArticleDOI
Short-term Costs of Preeclampsia to the United States Health Care System
Warren Stevens,Tiffany Shih,Devin Incerti,Thanh G.N. Ton,Henry C. Lee,Desi Peneva,George A. Macones,Bahaeddine M Sibai,Anupam B. Jena +8 more
TL;DR: 1. Marshall AL, Durani U, Bartley A, et al.
Journal ArticleDOI
Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a.
Melissa A. Frasco,Tiffany Shih,Devin Incerti,Oliver Díaz Espinosa,Diana K. Vania,Nina Thomas +5 more
TL;DR: Ocrelizumab provides greater value to RRMS patients compared with IFNβSC, and initiation at lower EDSS levels leads to a greater cumulative value due to slower disability progression, which extends years with higher quality-of-life.
Journal ArticleDOI
The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson's disease.
Tiffany Shih,Kavita Sail,Yash J. Jalundhwala,Jeffrey Sullivan,Emma van Eijndhoven,Cindy Zadikoff,Thomas S. Marshall,Darius N. Lakdawalla +7 more
TL;DR: Investigation of the relationship between functional status (FS) impairment and nursing home admission (NHA) risk in Parkinson’s disease (PD) patients and the effect of advanced PD treatment on NHA risk relative to standard of care found that patients with APD experience a higher risk in NHA than those with non-advanced disease.